Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study.

Successful transplantation of a donor kidney with diffuse proliferative lupus nephritis and crescents--a case report.

Adenovirus nephritis and obstructive uropathy in a renal transplant recipient: case report and literature review.

Human and murine kidneys show gender- and species-specific gene expression differences in response to injury.

Villous adenoma in the native kidney of a renal transplant recipient.

The effect of sirolimus on sex hormone levels of male renal transplant recipients.

No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.

Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction.

Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation.

Primary intestinal posttransplant T-cell lymphoma.

The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis.

Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.

Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis.